Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short term Debt: 2016-2025

Historic Short term Debt for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $64.6 million.

  • Collegium Pharmaceutical's Short term Debt changed negligibly% to $64.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $64.6 million for FY2024, which is 64.77% down from last year.
  • Collegium Pharmaceutical's Short term Debt amounted to $64.6 million in Q3 2025, which was down 0.00% from $64.6 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Short term Debt's 5-year high stood at $183.3 million during Q1 2023, with a 5-year trough of $47.7 million in Q1 2021.
  • Its 3-year average for Short term Debt is $129.4 million, with a median of $183.3 million in 2024.
  • Per our database at Business Quant, Collegium Pharmaceutical's Short term Debt spiked by 236.07% in 2022 and then slumped by 64.77% in 2024.
  • Collegium Pharmaceutical's Short term Debt (Quarterly) stood at $48.4 million in 2021, then skyrocketed by 236.07% to $162.5 million in 2022, then climbed by 12.82% to $183.3 million in 2023, then tumbled by 64.77% to $64.6 million in 2024, then remained steady at $64.6 million in 2025.
  • Its Short term Debt was $64.6 million in Q3 2025, compared to $64.6 million in Q2 2025 and $64.6 million in Q1 2025.